Effect of collagen powder on lymphorrhea after modified radical mastectomy. A randomized controlled trial

Aim: Postoperative lymphorrhea is a major complication of axillary lymphadenectomy. The aim of our study was to evaluate the impact of type I collagen in postoperative lymphorrhea in mastectomy patients. Methods: Eighty patients that underwent modified radical mastectomy for breast cancer were randomized in two groups. In group A (collagen group, n = 42) collagen type I (Cellerate RX powder) was applied in the axillary cavity after lymphadenectomy while in group B (control group, n = 38) lymphadenectomy was performed in the standard fashion without the use of a sealant. Suction drains remained in place until the daily amount of lymphatic drainage fell under 30 ml. The total amount and the duration of drainage, as well as the morbidity and severity of arm pain were compared in the two groups. Results: There was a non significant trend towards lower overall drainage in the collagen group. The duration of drainage and postoperative pain were similar in the two groups, as was morbidity. Subgroup analysis of patients according to the number of lymph nodes excised, revealed significantly less lymphorrhea in terms of volume and duration in patients who had more than ten lymph nodes excised. Conclusion: Collagen type I (Cellerate RX powder) appears to attenuate postoperative lymphorrhea in patients undergoing axillary lymphadenectomy especially when > 10 lymph nodes are removed.

Modified radical mastectomy; Lymphorrhea; Collagen

[1] Oertli D., Laffer U., Haberthuer F., Kreuter U., Harder F.: “Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer”. Br. J. Surg., 1994, 81, 856.

[2] Bonnema J., van Geel A.N., Ligtenstein D.A., Schmitz P.I., Wiggers T.: “A prospective randomized trial of high versus low vacuum drainage after axillary dissection for breast cancer”. Am. J. Surg., 1997, 173, 76.

[3] Divino C.M., Kuerer H.M., Tartter P.I.: “Drains prevent seromas following lumpectomy with axillary dissection”. Breast J., 2000, 6, 31.

[4] Christodoulakis M., Sanidas E., de Bree E., Michalakis J., Volakakis E., Tsiftsis D.: “Axillary lymphadenectomy for breast cancer - the influence of shoulder mobilisation on lymphatic drainage”. Eur. J. Surg. Oncol., 2003, 29, 303.

[5] Petrek J.A., Peters M.M., Nori S., Knauer C., Kinne D.W., Rogatko A.: “Axillary lymphadenectomy. A prospective, randomizedtrial of 13 factors influencing drainage, including early or delayed arm mobilization”. Arch. Surg., 1990, 125, 378.

[6] Lumachi F., Brandes A.A., Burelli P., Basso S.M., Iacobone M., Ermani M.: “Seroma prevention following axillary dissection inpatients with breast cancer by using ultrasound scissors: a prospective clinical study”. Eur. J. Surg. Oncol., 2004, 30, 526.

[7] Coveney E.C., O’Dwyer P.J., Geraghty J., O’Higgins N.J.: “Effect of closing dead space on seroma formation after mastectomy-a prospective randomized clinical trial”. Eur. J. Surg. Oncol., 1993, 19, 143.

[8] Chintamani, Singhal V., Singh J., Bansai A., Saxena S.: “Half versus full vacuum suction drainage after modified radical mastectomy for breast cancer - a prospective randomized clinical trial[ISRCTN24484328]”. BMC Cancer, 2005, 27, 11.

[9] Rice D.C., Morris S.M., Sarr M.G., Farnell M.B., Van Heerden J. A., Grant C.S. et al.: “Intraoperative topical tetracycline sclerotherapy following mastectomy: a prospective, randomized trial”. J. Surg. Oncol., 2000, 73, 224.

[10] Moore M., Burak W.E. Jr., Nelson E., Kearney T., Simmons R., Mayers L., Spotnitz W.D.: “Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: A randomized prospective clinical trial”. J. Am. Coll. Surg., 2001, 192,591.

[11] Carcoforo P., Soliani G., Maestroni U., Donini A., Inderbitzin D., Hui T.T. et al.: “Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial”. J. Am. Coll. Surg., 2003, 196, 365.

[12] Gilly F.N., François Y., Sayag-Beaujard A.C., Glehen O., Brachet A., Vignal J.: “Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial”. Eur. Surg. Res., 1998, 30, 439.

[13] Mustonen P.K., Härmä M.A., Eskelinen M.J.: “The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial”. Scand. J. Surg., 2004, 93, 209.

[14] Ko E., Han W., Cho J., Lee J.W., Kang S.Y., Jung S.Y. et al.: “Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial”. J. Korean Med. Sci., 2009, 24, 92.

[15] Carless P.A., Henry D.A.: “Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery”. Br. J. Surg., 2006, 93, 810.

[16] Dinsmore R.C., Harris J.A., Gustafson R.J.: “Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial”. Am. Surg., 2000, 66, 982.

[17] Kuroi K., Shimozuma K., Taguchi T., Imai H., Yamashiro H., Ohsumi S., Saito S.: “Evidence-based risk factors for seroma for-mation in breast surgery”. Jpn. J. Clin. Oncol., 2006, 36, 197.